Our professionals

Dr. Pedro Berraondo López

Principal Investigator of the Cytokine-Based Therapies group.

Be part of: Cima Universidad de Navarra Cancer Center Clínica Universidad de Navarra
INDEX H 49

Professional career

Bachelor's degree in Pharmacy in 1999 from the University of Navarra.

Doctorate in Pharmacy in 2004 from the University of Navarra.

Principal investigator within the Cytokine-Based Therapies Research Group within the Immunology and Immunotherapy Program.

RESEARCH AREAS

Co-author of 11 patents, 8 of them in collaboration with the pharmaceutical industry, licensed to companies such as Moderna Therapeutics and Genticel, or exploited by spin-offs such as Digna Therapeutics and Hepacyl.

He has participated in more than 190 scientific articles.

Principal investigator (PI) in 2 regional projects, 13 national projects, 3 international projects, and 10 projects with companies.

Translated with DeepL.com (free version)

AREAS OF INTEREST

  • Development of bifunctional molecules such as bispecifics or immunocytokines for the treatment of autoimmune diseases or cancer.
  • Use of mRNA for the development of new drugs.

Activity

In teaching

Co-director of the Expert Degree in Immuno-Oncology at the Faculty of Medicine of the University of Navarra.

In research

He has contributed to more than 110 scientific publications, including a publication in Nature as co-corresponding author, two publications in Nature Medicine (one as first co-author), and other works in Nature Reviews Drug Discovery, Cancer Cell, Immunity, and Cancer Discovery. 
More information

Icono Scopus   SCOPUS

Icono ORCID   ORCID

Icono RESEARCHID   RESEARCHID

Latest scientific publications

More information